We are live on ! Find out more
BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

11 hedge funds and large institutions have $3.34M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more funds holding

Funds holding: 8 → 11 (+3)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

24% more capital invested

Capital invested by funds: $2.7M → $3.34M (+$639K)

0.91% less ownership

Funds ownership: 16.24% → 15.34% (-0.91%)

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
–
Calls
$1.29M
Puts
–
Net Calls
+$1.29M
Net Calls Change
+$1.29M

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$663K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$482K
3
HF
HRT Financial
New York
+$367K
4
TRCT
Tower Research Capital (TRC)
New York
+$185K
5
Morgan Stanley
Morgan Stanley
New York
+$99.5K

Top Sellers

Rank Fund Capital Flow
1
WP
WealthSource Partners
California
-$971K
2
Citadel Advisors
Citadel Advisors
Florida
-$433K
3
UBS Group
UBS Group
Switzerland
-$21.2K

BIS Hedge Fund Activity: Q1 2020 in Review

11 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort NASDAQ Biotechnology (BIS) for Q1 2020, worth a combined $3.34M — up 24% from $2.7M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIS positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $663K. The largest seller was WealthSource Partners, cutting an estimated $971K.

  • 11 institutional investors held ProShares UltraShort NASDAQ Biotechnology (BIS) as of Q1 2020, up from 8 in Q4 2019.
  • Funds reported $3.34M of ProShares UltraShort NASDAQ Biotechnology stock for Q1 2020, up 24% quarter-over-quarter.
  • 3 funds opened new ProShares UltraShort NASDAQ Biotechnology positions in Q1 2020 and 0 closed out, a net change of +3 holders.
  • The largest ProShares UltraShort NASDAQ Biotechnology buyer in Q1 2020 was Jane Street, an estimated $663K added.
  • The largest ProShares UltraShort NASDAQ Biotechnology seller in Q1 2020 was WealthSource Partners, an estimated $971K sold.

Based on aggregated 13F filings for Q1 2020.